1
|
Applications and implications of the exponentially modified gamma distribution as a model for time variabilities related to cell proliferation and gene expression. J Theor Biol 2016; 393:203-17. [PMID: 26780652 DOI: 10.1016/j.jtbi.2015.12.027] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2015] [Revised: 12/07/2015] [Accepted: 12/16/2015] [Indexed: 12/22/2022]
Abstract
A panel of published distributions of cell interdivision times (IDT) comprising 77 datasets related to 16 cell types, some studied under different conditions, was used to evaluate their conformance to the exponentially modified gamma distribution (EMGD) in comparison with distributions suggested for IDT data earlier. Lognormal, gamma, inverse Gaussian, and shifted Weibull and gamma distributions were found to be generally inferior to EMGD. Exponentially modified Gaussian (EMG) performed equally well. Although EMGD or EMG may be worse than some other distributions in specific cases, the reason that IDT distributions must be generated by a common mechanism of the cell cycle makes it unlikely that they differ essentially in different cell types. Therefore, exponentially modified peak functions, such as EMGD or EMG, are most appropriate if the use of a single distribution for IDT data is reasonable. EMGD is also shown to be the best descriptive tool for published data on the distribution of times between the bursts of mRNA synthesis at defined genes in single cells. EMG is inadequate to such data because its Gaussian component markedly extends to the negative time domain. The applicability of EMGD to comparable features of cells and genes behaviors are discussed to support the validity of the transition probability model and to relate the exponential component of EMGD to the times of cell dwelling in the restriction point of the cell cycle.
Collapse
|
2
|
Corlu A, Loyer P. Regulation of the g1/s transition in hepatocytes: involvement of the cyclin-dependent kinase cdk1 in the DNA replication. Int J Hepatol 2012; 2012:689324. [PMID: 23091735 PMCID: PMC3471441 DOI: 10.1155/2012/689324] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/29/2012] [Accepted: 08/29/2012] [Indexed: 12/16/2022] Open
Abstract
A singular feature of adult differentiated hepatocytes is their capacity to proliferate allowing liver regeneration. This review emphasizes the literature published over the last 20 years that established the most important pathways regulating the hepatocyte cell cycle. Our article also aimed at illustrating that many discoveries in this field benefited from the combined use of in vivo models of liver regeneration and in vitro models of primary cultures of human and rodent hepatocytes. Using these models, our laboratory has contributed to decipher the different steps of the progression into the G1 phase and the commitment to S phase of proliferating hepatocytes. We identified the mitogen dependent restriction point located at the two-thirds of the G1 phase and the concomitant expression and activation of both Cdk1 and Cdk2 at the G1/S transition. Furthermore, we demonstrated that these two Cdks contribute to the DNA replication. Finally, we provided strong evidences that Cdk1 expression and activation is correlated to extracellular matrix degradation upon stimulation by the pro-inflammatory cytokine TNFα leading to the identification of a new signaling pathway regulating Cdk1 expression at the G1/S transition. It also further confirms the well-orchestrated regulation of liver regeneration via multiple extracellular signals and pathways.
Collapse
Affiliation(s)
- Anne Corlu
- Inserm UMR S 991, Foie Métabolismes et Cancer, Université de Rennes 1, Hôpital Pontchaillou, 35033 Rennes Cedex, France
| | - Pascal Loyer
- Inserm UMR S 991, Foie Métabolismes et Cancer, Université de Rennes 1, Hôpital Pontchaillou, 35033 Rennes Cedex, France
| |
Collapse
|
3
|
Kalaszczynska I, Geng Y, Iino T, Mizuno SI, Choi Y, Kondratiuk I, Silver DP, Wolgemuth DJ, Akashi K, Sicinski P. Cyclin A is redundant in fibroblasts but essential in hematopoietic and embryonic stem cells. Cell 2009; 138:352-65. [PMID: 19592082 PMCID: PMC2745999 DOI: 10.1016/j.cell.2009.04.062] [Citation(s) in RCA: 161] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/24/2008] [Revised: 03/15/2009] [Accepted: 04/29/2009] [Indexed: 11/30/2022]
Abstract
Cyclins are regulatory subunits of cyclin-dependent kinases. Cyclin A, the first cyclin ever cloned, is thought to be an essential component of the cell-cycle engine. Mammalian cells encode two A-type cyclins, testis-specific cyclin A1 and ubiquitously expressed cyclin A2. Here, we tested the requirement for cyclin A function using conditional knockout mice lacking both A-type cyclins. We found that acute ablation of cyclin A in fibroblasts did not affect cell proliferation, but led to prolonged expression of another cyclin, cyclin E, across the cell cycle. However, combined ablation of all A- and E-type cyclins extinguished cell division. In contrast, cyclin A function was essential for cell-cycle progression of hematopoietic and embryonic stem cells. Expression of cyclin A is particularly high in these compartments, which might render stem cells dependent on cyclin A, whereas in fibroblasts cyclins A and E play redundant roles in cell proliferation.
Collapse
Affiliation(s)
- Ilona Kalaszczynska
- Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Yan Geng
- Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Tadafumi Iino
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Shin-ichi Mizuno
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Yoon Choi
- Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Ilona Kondratiuk
- Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Daniel P. Silver
- Department of Medical Oncology, Dana-Farber Cancer Institute, and Department of Medicine Harvard Medical School, Boston, MA 02115, USA
| | - Debra J. Wolgemuth
- Departments of Genetics and Development and Obstetrics and Gynecology, Columbia University Medical Center, New York, NY 10032, USA
| | - Koichi Akashi
- Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| | - Piotr Sicinski
- Department of Cancer Biology, Dana-Farber Cancer Institute and Department of Pathology, Harvard Medical School, Boston, MA 02115, USA
| |
Collapse
|